Shuai Y - Search Results

1

EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations.

Chiosea S, Shuai Y, Cieply K, Nikiforova MN, Dacic S. Chiosea S, et al. Among authors: shuai y. Hum Pathol. 2010 Aug;41(8):1053-60. doi: 10.1016/j.humpath.2010.01.008. Epub 2010 Apr 8. Hum Pathol. 2010. PMID: 20381121

2

Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.

Dacic S, Kothmaier H, Land S, Shuai Y, Halbwedl I, Morbini P, Murer B, Comin C, Galateau-Salle F, Demirag F, Zeren H, Attanoos R, Gibbs A, Cagle P, Popper H. Dacic S, et al. Among authors: shuai y. Virchows Arch. 2008 Dec;453(6):627-35. doi: 10.1007/s00428-008-0689-3. Epub 2008 Oct 29. Virchows Arch. 2008. PMID: 18958493

3

Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas.

Dacic S, Shuai Y, Yousem S, Ohori P, Nikiforova M. Dacic S, et al. Among authors: shuai y. Mod Pathol. 2010 Feb;23(2):159-68. doi: 10.1038/modpathol.2009.154. Epub 2009 Oct 23. Mod Pathol. 2010. PMID: 19855375 Free article.

4

miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.

Dacic S, Kelly L, Shuai Y, Nikiforova MN. Dacic S, et al. Among authors: shuai y. Mod Pathol. 2010 Dec;23(12):1577-82. doi: 10.1038/modpathol.2010.152. Epub 2010 Sep 3. Mod Pathol. 2010. PMID: 20818338 Free article.

5

Phase II study of everolimus (RAD001) in previously treated small cell lung cancer.

Tarhini A, Kotsakis A, Gooding W, Shuai Y, Petro D, Friedland D, Belani CP, Dacic S, Argiris A. Tarhini A, et al. Among authors: shuai y. Clin Cancer Res. 2010 Dec 1;16(23):5900-7. doi: 10.1158/1078-0432.CCR-10-0802. Epub 2010 Nov 2. Clin Cancer Res. 2010. PMID: 21045083 Clinical Trial.

6

The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.

Monaco SE, Shuai Y, Bansal M, Krasinskas AM, Dacic S. Monaco SE, et al. Among authors: shuai y. Am J Clin Pathol. 2011 Apr;135(4):619-27. doi: 10.1309/AJCPP5R2ZJZKCLWN. Am J Clin Pathol. 2011. PMID: 21411785

7

MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.

Yip L, Kelly L, Shuai Y, Armstrong MJ, Nikiforov YE, Carty SE, Nikiforova MN. Yip L, et al. Among authors: shuai y. Ann Surg Oncol. 2011 Jul;18(7):2035-41. doi: 10.1245/s10434-011-1733-0. Epub 2011 May 3. Ann Surg Oncol. 2011. PMID: 21537871 Free PMC article.

8

Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristics.

Yu J, Dabbs DJ, Shuai Y, Niemeier LA, Bhargava R. Yu J, et al. Among authors: shuai y. Am J Clin Pathol. 2011 Jul;136(1):88-97. doi: 10.1309/AJCP7URIW0QETTAT. Am J Clin Pathol. 2011. PMID: 21685036

9

Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.

Brcic L, Sherer CK, Shuai Y, Hornick JL, Chirieac LR, Dacic S. Brcic L, et al. Among authors: shuai y. Am J Clin Pathol. 2012 Nov;138(5):712-8. doi: 10.1309/AJCP05TTWQTWNLTN. Am J Clin Pathol. 2012. PMID: 23086772

10

Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local Control.

Maxwell JH, Thompson LD, Brandwein-Gensler MS, Weiss BG, Canis M, Purgina B, Prabhu AV, Lai C, Shuai Y, Carroll WR, Morlandt A, Duvvuri U, Kim S, Johnson JT, Ferris RL, Seethala R, Chiosea SI. Maxwell JH, et al. Among authors: shuai y. JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1104-10. doi: 10.1001/jamaoto.2015.1351. JAMA Otolaryngol Head Neck Surg. 2015. PMID: 26225798 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters